- Original Paper
- Published:
Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells
Oncogenevolume 20, pages3880–3887 (2001)Cite this article
1533Accesses
149Citations
9Altmetric
Abstract
Androgen signaling influences the development and growth of prostate carcinoma. The transcriptional activity of androgen receptor (AR) is regulated by positive or negative transcriptional cofactors. We report here that PIAS1, PIAS3, and PIASy of the protein inhibitor of activated STAT (PIAS) family, which are expressed in human prostate, display distinct effects on AR-mediated gene activation in prostate cancer cells. While PIAS1 and PIAS3 enhance the transcriptional activity of AR, PIASy acts as a potent inhibitor of AR in prostate cancer cells. The effects of PIAS proteins on AR are competitive. PIASy binds to AR but does not affect the DNA binding activity of AR. An NH2-terminal LXXLL signature motif of PIASy, although not required for PIASy–AR interaction, is essential for the transrepression activity of PIASy. Our results identify PIASy as a transcriptional corepressor of AR and suggest that different PIAS proteins have distinct effects on AR signaling in prostate cancer cells.
This is a preview of subscription content,access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
¥40,000 per year
only ¥800 per issue
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
References
Abreu-Martin MT, Chari A, Palladino AA, Craft NA, Sawyers CL . 1999Mol. Cell. Biol.19: 5143–5154
Bentel JM, Tilley WD . 1996J. Endocrinol.151: 1–11
Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K . 1997Science278: 1803–1805
Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR . 1998Genes Dev.12: 3343–3356
Darnell Jr JE . 1997Science277: 1630–1635
Freedman LP . 1999Cell97: 5–8
Glass CK, Rosenfeld MG . 2000Genes Dev.14: 121–141
Heery DM, Kalkhoven E, Hoare S, Parker MG . 1997Nature387: 733–736
Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L . 1996Mol. Endocrinol.10: 1167–1177
Hu X, Lazar MA . 1999Nature402: 93–96
Huang W, Shostak Y, Tarr P, Sawyers C, Carey M . 1999J. Biol. Chem.274: 25756–25768
Khan KD, Shuai K, Lindwall G, Maher SE, Darnell Jr JE, Bothwell AL . 1993Proc. Natl. Acad. Sci. USA90: 6806–6810
Kokontis JM, Liao S . 1999Vitam. Horm.55: 219–307
Liao J, Fu Y, Shuai K . 2000Proc. Natl. Acad. Sci. USA97: 5267–5272
Liu B, Gross M, ten Hoeve J, Shuai K . 2001Proc. Natl. Acad. Sci. USA98: 3203–3207
Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K . 1998Proc. Natl. Acad. Sci. USA95: 10626–10631
McDonald S, Brive L, Agus DB, Scher HI, Ely KR . 2000Cancer Res.60: 2317–2322
McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG . 1998Genes Dev.12: 3357–3368
Moilanen AM, Karvonen U, Poukka H, Yan W, Toppari J, Jeanne OA, Palvimo JJ . 1999J. Biol. Chem.274: 3700–3704
Nagy L, Kao HY, Love JD, Li C, Banayo E, Gooch JT, Krishna V, Chatterjee K, Evans RM, Schwabe JW . 1999Genes Dev.13: 3209–3216
Neaear AM, Beaurang PA, Zhou S, Abraham S, Solomon W, Tjian R . 1999Nature398: 828–832
Parker SL, Tong T, Bolden S, Wingo PA . 1997CA Cancer J. Clin.47: 5–27
Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK, Rosenfeld MG . 1999Genes Dev.13: 3198–3208
Rachez C, Lemon DB, Suldan Z, Bromleigh V, Gamble M, Neaear AM, Erdjument-Bromage H, Tempst P, Freedman LP . 1999Nature398: 824–828
Shuai K . 1999Prog. Biophys. Mol. Biol.71: 405–422
Shuai K . 2000Oncogene19: 2638–2644
Shuai K, Schindler C, Prezioso VR, Darnell Jr JE . 1992Science258: 1808–1812
Tan J, Hall SH, Hamil KG, Grossman G, Petrusz P, Liao J, Shuai K, French FS . 2000Mol. Endocrinol.14: 14–24
Torchia J, Glass C, Rosenfeld MG . 1998Curr. Opin. Cell. Biol.10: 373–383
Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG . 1997Nature387: 677–684
Trapman J., Cleutjens KB . 1997Semin. Cancer Biol.8: 29–36
Acknowledgements
We thank C Sawyers for discussion and reading the manuscript; X Rao and M Sohn for technical assistance. B Liu is a Cancer Research Institute fellow. Supported by a grant from the NIH (AI43438).
Author information
Authors and Affiliations
Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, 90095, California, CA, USA
Mitchell Gross, Bin Liu & Ke Shuai
Department of Biological Chemistry, University of California, Los Angeles, 90095, California, CA, USA
Michael Carey & Ke Shuai
Department of Pediatrics, The Laboratories for Reproductive Biology, University of North Carolina School of Medicine, Chapel Hill, 27599-7500, North Carolina, NC, USA
Jiann-an Tan & Frank S French
- Mitchell Gross
You can also search for this author inPubMed Google Scholar
- Bin Liu
You can also search for this author inPubMed Google Scholar
- Jiann-an Tan
You can also search for this author inPubMed Google Scholar
- Frank S French
You can also search for this author inPubMed Google Scholar
- Michael Carey
You can also search for this author inPubMed Google Scholar
- Ke Shuai
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Gross, M., Liu, B., Tan, Ja.et al. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.Oncogene20, 3880–3887 (2001). https://doi.org/10.1038/sj.onc.1204489
Received:
Revised:
Accepted:
Published:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Keywords
This article is cited by
ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p–PIAS3–AKT2 signaling axis
- Jen-Chih Tseng
- Shih-Han Huang
- Chih-Pin Chuu
Cell Death & Disease (2020)
Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility
- Chongyang Li
- Francis P. McManus
- Pierre Thibault
Nature Communications (2020)
The conserved ancient role of chordate PIAS as a multilevel repressor of the NF-κB pathway
- Ruihua Wang
- Shengfeng Huang
- Anlong Xu
Scientific Reports (2017)
PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer
- M Puhr
- J Hoefer
- Z Culig
Oncogene (2016)
Androgen receptor signaling in prostate cancer
- Zoran Culig
- Frédéric R. Santer
Cancer and Metastasis Reviews (2014)